Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Kiora Pharmaceuticals, Inc. (KPRX) had Return on Investments of -17.35% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.42M |
|
-- |
|
-- |
|
$2.51M |
|
$-2.51M |
|
$0.09M |
|
$-2.42M |
|
$-2.42M |
|
$-2.42M |
|
$-2.42M |
|
$-2.42M |
|
$-2.42M |
|
$-2.51M |
|
$-2.50M |
|
4.17M |
|
4.17M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$18.68M |
|
$0.09M |
|
$2.54M |
|
$21.23M |
|
$2.80M |
|
-- |
|
$4.49M |
|
$7.29M |
|
$13.93M |
|
$11.87M |
|
$13.93M |
|
3.99M |
|
| Cash Flow Statement Financials | |
$-3.16M |
|
$5.40M |
|
$-0.00M |
|
$8.70M |
|
$10.96M |
|
$2.26M |
|
$0.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.35% |
|
-20.37% |
|
-11.39% |
|
|
Return on Investments |
-17.35% |
$3.49 |
|
$-0.76 |
|
$-0.76 |
|